Archive

ADA 2014 Report: Insulin not associated with increased Cancer risk

Written by Lorraine Carolan | 4 Jul 2014

Despite some concerns to the contrary, the use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes,… read more.

Insulin not associated with cancer

Written by Lorraine Carolan | 2 Jul 2014

Despite some concerns to the contrary, the use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes,… read more.

Diabetes care depends on how your doctor is paid

Written by Lorraine Carolan | 30 Jun 2014

From 2006 to 2008, nearly 75 per cent of patients with diabetes living in Ontario did not receive all of the tests recommended to properly monitor their disease…. read more.

ASCO 2014 Report – Younger colon cancer patients diagnosed with more advanced disease, but have better survival rates at all stages

Written by Bruce Sylvester | 27 Jun 2014

by Bruce Sylvester – Colon cancer patients diagnosed before age 50 have more advanced stages of colon cancer at diagnosis but have better survival at all stages of… read more.

Pooled analysis of two Phase III Trials shows Halaven® (Eribulin) improves survival in advanced breast cancer

Written by Lorraine Carolan | 26 Jun 2014

Significant survival benefit observed in women with HER2 negative breast cancer – ASCO Press Release.

Lenvatinib Phase III results show significant improvement in progression-free survival in people with Radioiodine-Refractory differentiated Thyroid Cancer

Written by Lorraine Carolan | 26 Jun 2014

Pivotal phase III data for lenvatinib to be presented in a Head and Neck Cancer oral session at American Society of Clinical Oncology congress (ASCO) – Press Release.

Indentification of independent risk factors in rectal cancer could affect treatment planning

Written by Bruce Sylvester | 26 Jun 2014

by Bruce Sylvester – Researchers report that a pooled analysis of two major trials suggests that short- and long-term outcomes of neoadjuvant chemotherapy followed by chemoradiotherapy in high-risk… read more.

ASCO 2014 Report: First line treatment efficacy in colorectal cancer affected by gender and tumor location

Written by Bruce Sylvester | 25 Jun 2014

by Bruce Sylvester – Gender and tumor location predict efficacy in first-line treatment metastatic colorectal cancer, researchers reported a poster presentation at ASCO 2014.

E-cigarette vapour and MRSA

Written by Lorraine Carolan | 20 Jun 2014

In laboratory studies, e-cigarette vapours appeared to increase the aggressiveness of dangerous bacteria such as methicillin-resistant Staphylococcus aureus (MRSA).

Focused ultrasound reduces cancer pain

Written by Lorraine Carolan | 12 Jun 2014

Non-invasive focused ultrasound thermal therapy reduces pain from bone metastases. When cancer progresses and spreads to the bone, patients often suffer debilitating pain. Now, a new phase III… read more.

ASCO 2014 Report: Genetic SNP appears to be predictive of utility of cetuximab in metastatic colorectal cancer

Written by Bruce Sylvester | 11 Jun 2014

by Bruce Sylvester – The presence of the single nucleotide polymorphism (SNP) rs895374, located in UbcH7, an E2 ligase conducting neddylation of HECT E3 ligases involved in EGFR… read more.

ASCO 2014 Report: In metastatic colorectal cancer treatment, overall survival is similar for continuous delivery and intermittent delivery

Written by Bruce Sylvester | 11 Jun 2014

by Bruce Sylvester – Intermittent strategies for delivering systemic treatment in metastatic colorectal cancer show no clinically significant superiority in overall survival rates when compared to continuous delivery,… read more.

« Previous 1 … 21 22 23 24 25 … 48 Next »

Archive

Subscribe for our mailing list

Follow Us